I

Institut Jantung Negara | Clinical Research Department

Research site

(Unclaimed)

Location

145 Jalan Tun Razak, Kuala Lumpur, Selangor, Malaysia

Site insights

Top conditions

Top treatments

Macitentan

JNJ-67896049

Tocotrienols

Rocuronium

Thienopyridine

Nitric Oxide

Pradaxa

Apixaban

Medication

Vitamin K

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 36 total trials

A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation (LIBREXIA-AF)

The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-cent...

Enrolling

Atrial Fibrillation

Drug: Apixaban Placebo

Drug: Milvexian

A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH) (TOMORROW)

This is a prospective, multicenter, open-label, randomized, controlled, parallel Phase 3 study with an open-label single-arm extension period to eval...

Active, not recruiting

Pulmonary Arterial Hypertension

Drug: Macitentan

Other: Standard-of-care

Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents Versus Everolimus-Eluting Stents in Coronary Artery Disease Patients With Diabetes Mellitus Global (ABILITY)

To compare in diabetic patients eligible for percutaneous coronary intervention (PCI) with minimal exclusion criteria, the efficacy and safety of Abl...

Active, not recruiting

Coronary Artery Disease

Diabetes

Device: XIENCE Everolimus Eluting Coronary Stent System (XIENCE family)

Device: Abluminus DES+ Sirolimus Eluting Stent System (SES)